School of Medicine
Showing 871-880 of 1,296 Results
-
Blake Marleau Snyder
Clinical Instructor, Ophthalmology
BioBlake Snyder, MD grew up in Colorado and brings his love of skiing, biking, hiking, and live music to a life and career focused on global ophthalmology. He studied biochemistry and chemistry at the University of Colorado, graduating summa cum laude as the only student in his department to do so, with distinction and Phi Beta Kappa honors. He then spent a year as an Intramural Research Training Award Fellow at the National Institutes of Health, where he was first introduced to ophthalmology. During medical school, he was one of six students selected as an AOA Honor Society leader and received both the departmental award in ophthalmology at graduation and a full presidential scholarship. He spent two years completing international ophthalmology research as a Doris Duke/Fogarty Fellow with the Francis I. Proctor Foundation at UCSF, contributing to a project later supported by the Bill & Melinda Gates Foundation. He completed residency at UC Davis, where he served as Chief Resident and co-authored a policy paper that helped advance Congressional legislation on corneal donation access for minority populations. He returned to UCSF and the Proctor Foundation for fellowship training in uveitis and medical cornea and is now a Global Ophthalmology Fellow at Stanford.
-
Michael Snyder, Ph.D.
Stanford W. Ascherman Professor of Genetics
Current Research and Scholarly InterestsOur laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states
-
Samuel So, MD
Lui Hac Minh Professor in the School of Medicine
Current Research and Scholarly InterestsThrough a 4 pronged comprehensive program: translational and clinical research, early detection and treatment, promoting education, awareness and immunization and building partnership, we are working towards the development of new strategies that will lead to the elimination of hepatitis B worldwide and reduce the threat and incidence of liver cancer. Current research efforts focus on evaluating potential new diagnostic and treatment markers and novel targeted therapy for primary liver cancer.